{"id":985053,"date":"2026-08-06T18:12:18","date_gmt":"2026-08-06T18:12:18","guid":{"rendered":"https:\/\/www.europesays.com\/us\/985053\/"},"modified":"2026-08-06T18:12:18","modified_gmt":"2026-08-06T18:12:18","slug":"3-widely-prescribed-medicines-classified-as-cancer-causing-by-who","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/985053\/","title":{"rendered":"3 widely-prescribed medicines classified as cancer-causing by WHO"},"content":{"rendered":"<p>Three widely-prescribed medicines used to treat high BP, fungal infections, and organ transplant rejection have been classified as carcinogenic to humans (Group 1) by WHO&#8217;s cancer agency. These include hydrochlorothiazide, voriconazole, and tacrolimus. Experts said the classification is a hazard identification and should not prompt patients to discontinue treatment without consultation.<\/p>\n","protected":false},"excerpt":{"rendered":"Three widely-prescribed medicines used to treat high BP, fungal infections, and organ transplant rejection have been classified as&hellip;\n","protected":false},"author":3,"featured_media":985054,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[104,395163,395162,3240,106,17407,210,82079,105,728,1060,122,50,82076,67,132,68,395161,82078,82077,82075],"class_list":["post-985053","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-breaking-news","tag-cancercausing","tag-classified","tag-current-affairs","tag-current-news","tag-daily-news","tag-health","tag-health___fitness","tag-latest-news","tag-local-news","tag-medication","tag-medicines","tag-news","tag-news-online","tag-united-states","tag-unitedstates","tag-us","tag-widelyprescribed","tag-82078","tag-82077","tag-82075"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/117049920606318173","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/985053","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=985053"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/985053\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/985054"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=985053"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=985053"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=985053"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}